Moradinia, Mehdi
Yarahmadi, Sajad
Birjandi, Mehdi
Gholami, Mohammad
Article History
Received: 26 December 2024
Accepted: 29 April 2025
First Online: 12 May 2025
Declarations
:
: This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. Ethical approval was obtained from the Ethics Committee of Lorestan University Medical of Sciences, and the study was assigned the ethical code IR.UMS.REC.1402.173. The clinical trial was also registered with the Iranian Registry of Clinical Trials (IRCT) under the registration number IRCT20150919024080N23, with a registration date of January 2, 2024.
: Participants were provided detailed information about the study objectives, procedures, potential benefits, and risks. Before enrolling in the study, written informed consent was obtained from all participants. Confidentiality and anonymity were ensured by securely storing their personal and medical information and using de-identified data for analysis and reporting.
: Not Applicable.
: The authors declare no competing interests.